Latest Headlines

  1. AGC Biologics Joins Orphan Therapeutics Accelerator's Clinical Development Network As A Manufacturing Partner To Advance Cell And Gene Therapies For Ultra-Rare Diseases 5/14/2026

    Orphan Therapeutics Accelerator (OTXL), a non-profit biotech focused on completing development and enabling commercial access to stalled rare disease treatments, today announced that AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has joined OTXL’s Clinical Development Network (Orphan ClinDevNet) as a manufacturing partner.

  2. Aldevron And Minaris Renew Lentiviral Plasmid Agreement 5/14/2026

    FARGO, N.D. & PHILADELPHIA–(BUSINESS WIRE)–Aldevron, a Danaher company and global leader in the production of DNA, RNA and protein for genomic medicine, and Minaris, a global cell and gene therapy contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider today announced a renewed licensing agreement that expands access to a proprietary, off-the-shelf lentiviral plasmid system for gene-modified cell therapy applications.

  3. Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery 5/12/2026

    Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), the medicine performance‑enhancing company, today announced that it has signed an exclusivity agreement with a U.S. biopharmaceutical company (Nasdaq listed, Mcap USD 1Bn+) for the application of Nanoform’s proprietary biologics nanoparticle technology to support the development of differentiated subcutaneous biologic medicines.

  4. 3PBIOVIAN Strengthens Its End-To-End CDMO Offering With State-Of-The-Art Sterility Testing, From Clinical To Commercial 5/7/2026

    3PBIOVIAN has significantly strengthened its sterility testing capabilities, reinforcing its position as an integrated, end-to-end CDMO serving biopharma customers from early development through commercial supply.

  5. Notes From The Road: INTERPHEX 2026 5/7/2026
  6. 3P innovation Wins King's Award For Enterprise In Innovation For cryoFIL® Technology 5/6/2026
  7. Made Scientific And RoosterBio Announce Strategic Technology And Supply Partnership To Expand Scalable MSC And Extracellular Vesicle Manufacturing 5/5/2026

    Partnership integrates RoosterBio's mesenchymal stem cell and extracellular vesicle platforms into Made Scientific's end-to-end CDMO capabilities to accelerate development and commercial-scale production of advanced therapies.

  8. 3P innovation Launches Next-Generation DPI Filling Technology For Novel Inhalation Therapeutics 4/30/2026

    3P innovation, an international automation company specialising in high-precision liquid and powder drug filling systems, today announces market availability of its new, generic next-generation dry powder inhaler (DPI) filling technology.

  9. Mikron Automation And 3P innovation Announce Strategic Partnership For Integrated DPI Manufacturing Solution 4/29/2026
  10. AES Cleanroom Technology appoints John Groth As Chief Revenue Officer 4/27/2026

    AES Cleanroom Technology, a leading provider of modular cleanroom design, manufacturing, and construction solutions for the life sciences and biopharmaceutical industries, has appointed John Groth as Chief Revenue Officer as demand grows for flexible, high-performance manufacturing environments across pharma and biotech.